Literature DB >> 33643318

Update on Infections in Primary Antibody Deficiencies.

Yesim Yilmaz Demirdag1, Sudhir Gupta1.   

Abstract

Bacterial respiratory tract infections are the hallmark of primary antibody deficiencies (PADs). Because they are also among the most common infections in healthy individuals, PADs are usually overlooked in these patients. Careful evaluation of the history, including frequency, chronicity, and presence of other infections, would help suspect PADs. This review will focus on infections in relatively common PADs, discussing diagnostic challenges, and some management strategies to prevent infections.
Copyright © 2021 Demirdag and Gupta.

Entities:  

Keywords:  IgG subclass deficiency; common variable immunodeficiency; immunoglobulin therapy; infections; primary immunodeficiencies; selective IgA deficiency; selective IgM deficiency; specific antibody deficiency

Year:  2021        PMID： 33643318      PMCID： PMC7905085          DOI： 10.3389/fimmu.2021.634181

Source DB:  PubMed          Journal:  Front Immunol        ISSN： 1664-3224            Impact factor:   7.561


  166 in total

1.  Autosomal recessive agammaglobulinemia associated with an IGLL1 gene missense mutation.

Authors:  Kristina T Gemayel; Gary W Litman; Panida Sriaroon
Journal:  Ann Allergy Asthma Immunol       Date:  2016-08-27       Impact factor: 6.347

2.  Achromobacter xylosoxidans Sepsis Unveiling X-linked Agammaglobulinemia Masquerading as Systemic-onset Juvenile Idiopathic Arthritis.

Authors:  Mahesh Janarthanan; Sameera Gollapalli; Shuba Sankaranarayanan
Journal:  Indian Pediatr       Date:  2019-05-15       Impact factor: 1.411

3.  B-cell Deficiency: A De Novo IKZF1 Patient and Review of the Literature.

Authors:  Q Y Chen; X C Wang; W J Wang; Q H Zhou; D R Liu; Y Wang
Journal:  J Investig Allergol Clin Immunol       Date:  2018       Impact factor: 4.333

Review 4.  PI3K pathway defects leading to immunodeficiency and immune dysregulation.

Authors:  Cristiane J Nunes-Santos; Gulbu Uzel; Sergio D Rosenzweig
Journal:  J Allergy Clin Immunol       Date:  2019-05       Impact factor: 10.793

5.  Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.

Authors:  Li Zhang; Lin Radigan; Ulrich Salzer; Timothy W Behrens; Bodo Grimbacher; George Diaz; James Bussel; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

6.  Selective immunoglobulin M deficiency in an adult with Streptococcus pneumoniae sepsis and invasive aspergillosis.

Authors:  R Hong; S Gupta
Journal:  J Investig Allergol Clin Immunol       Date:  2008       Impact factor: 4.333

7.  Helicobacter cinaedi-Associated Refractory Cellulitis in Patients with X-Linked Agammaglobulinemia.

Authors:  Kento Inoue; Saeko Sasaki; Takahiro Yasumi; Kohsuke Imai; Takashi Kusunoki; Tomohiro Morio; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2020-09-10       Impact factor: 8.317

8.  Selective IgA deficiency with 18q+ and 18q-- karyotypic anomalies.

Authors:  R M Lewkonia; C C Lin; R H Haslam
Journal:  J Med Genet       Date:  1980-12       Impact factor: 6.318

9.  Autosomal recessive agammaglobulinemia due to defect in μ heavy chain caused by a novel mutation in the IGHM gene.

Authors:  P Silva; A Justicia; A Regueiro; S Fariña; J M Couselo; L Loidi
Journal:  Genes Immun       Date:  2017-08-03       Impact factor: 2.676

10.  Mutations of the Igbeta gene cause agammaglobulinemia in man.

Authors:  Simona Ferrari; Vassilios Lougaris; Stefano Caraffi; Roberta Zuntini; Jianying Yang; Annarosa Soresina; Antonella Meini; Giantonio Cazzola; Cesare Rossi; Michael Reth; Alessandro Plebani
Journal:  J Exp Med       Date:  2007-08-20       Impact factor: 14.307
View more
  2 in total

1.  Serum Immunoglobulins, Pneumonia Risk, and Lung Function in Middle-Aged and Older Individuals: A Population-Based Cohort Study.

Authors:  Samer R Khan; Anna Vanoverschelde; Lies Lahousse; Robin P Peeters; P Martin van Hagen; Guy Brusselle; Layal Chaker; Virgil A S H Dalm
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

2.  Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients.

Authors:  Maria Giovanna Danieli; Jacopo Umberto Verga; Cristina Mezzanotte; Irene Terrenato; Silvia Svegliati; Maria Beatrice Bilo; Gianluca Moroncini
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.